Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous tumour-derived gp96 heat shock protein-peptide complex

EU orphan designation number: EU/3/09/624   
Active ingredient: Autologous tumour-derived gp96 heat shock protein-peptide complex
Indication: Treatment of glioma
Sponsor: Antigenics Therapeutics Limited
25/28 North Wall Quay, Dublin 1, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/05/2009 Orphan designation EMEA/OD/104/08 (2009)3454 of 29/04/2009